GB1052589A - - Google Patents
Info
- Publication number
- GB1052589A GB1052589A GB1052589DA GB1052589A GB 1052589 A GB1052589 A GB 1052589A GB 1052589D A GB1052589D A GB 1052589DA GB 1052589 A GB1052589 A GB 1052589A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vessel
- solutions
- natural
- layers
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Prostheses (AREA)
Abstract
1,052,589. Artificial veins, arteries &c. H. THIELE. July 26, 1965 [July 25, 1964], No. 31863/65. Heading A5R. The invention relates to a process in which a natural vein or like vessel is dissolved and an artificial vein or like vessel is subsequently reconstituted from solution. The term "like vessel" is defined to include arteries, for example aortas, and other blood vessels, tracheae and like tubular body parts. The invention comprises, in one aspect, producing a series of solutions, in each of which is dissolved a histologically defined layer of a natural body vessel and from which may be prepared artificial body vessels, by the steps of causing a natural vessel to swell, mechanically separating the swollen vessel into layers according to the histological structure of the vessel, and separately dissolving each layer in a solvent without affecting the protein components of the layer. Advantageously, the vessel is separted into extema, media and intima layers from which layers three solutions may be obtained. The solvent for the layers may be a weak organic acid, for example pyruvic, lactic, tartaric or citric acid, or an alkaline solution, for example a solution of an alkali metal hydroxide such as sodium hydroxide, or of urea or a derivative of urea, or a solution of an alkali metal thiocyanate, for example lithium thiocyanate. The layers preferably are dissolved at a temperature not greater than 27‹C. to minimise physiological damage. Prior to being caused to swell, the natural vessel may be treated with a defattening agent, for example methanol, ethanol or acetone, either alone or mixed with dimethoxy methane; a suitable agent comprises a mixture of 4 volumes methanol and 1 volume dimethoxy methane. After being defatted, the natural vessel may be treated with an agent to dissolve out the mucopolysaccharides and uronic acids that are present; this agent, which may be an aqueous acid or alkaline solution, for example aqueous sodium hydroxide, may also be capable of swelling the natural vessel so that such dissolution and swelling occur simultaneously. By successively causing a series of solutions, prepared as above, to gel and precipitate around a mould of the desired shape, there may be obtained an artificial body vessel constituted by superposed layers of the gel's formed from each solution and having a histological structure corresponding to that of the original natural vessel. If mucopolysaccharides and uronic acids were removed from the natural vessel after defattening, these substances are added to the series of solutions prior to the gelling and precipitation stress. The superposed layers of the gel may subsequently be immersed in blood serum to absorb serum components. The solutions may be caused to gel and precipitate by allowing gel-forming ions, for example hydrogen ions or multivalent metal cations (calcium, copper, cadmium, aluminium and lantharum cations are specified), to diffuse into the solutions, or by suitably adjusting the pH of the solutions, or by electrophoresis using the mould as a membrane in an electrodialyzer. After gelling and precipitation have been effected the metal cations may be exchanged with hydrogen ions by treatment with, for example, dilute acetic acid; excess hydrogen ions may be removed by dialysis.
Publications (1)
Publication Number | Publication Date |
---|---|
GB1052589A true GB1052589A (en) |
Family
ID=1757091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1052589D Active GB1052589A (en) |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1052589A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007003324A3 (en) * | 2005-06-30 | 2007-08-16 | Transtissue Technologies Gmbh | Cell-free graft consisting of a matrix and a serum |
US8734828B2 (en) | 2006-10-06 | 2014-05-27 | Biotissue Ag | Matrix-gel graft without cells |
-
0
- GB GB1052589D patent/GB1052589A/en active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007003324A3 (en) * | 2005-06-30 | 2007-08-16 | Transtissue Technologies Gmbh | Cell-free graft consisting of a matrix and a serum |
AU2006265361B2 (en) * | 2005-06-30 | 2009-10-22 | Biotissue Ag | Cell-free graft consisting of a matrix and a serum |
JP4871356B2 (en) * | 2005-06-30 | 2012-02-08 | ビオティッシュー アーゲー | Cell-free graft |
DE102005030614B4 (en) * | 2005-06-30 | 2014-05-08 | Biotissue Ag | Cell-free graft, its use, process for its preparation, matrix thus produced with gel and process for the preparation of this matrix with gel |
US9125871B2 (en) | 2005-06-30 | 2015-09-08 | Biotissue Ag | Cell-free graft |
US8734828B2 (en) | 2006-10-06 | 2014-05-27 | Biotissue Ag | Matrix-gel graft without cells |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3645226C2 (en) | ||
JP4230135B2 (en) | Method for producing glycosaminoglycan-collagen complex cross-linked by multifunctional cross-linking agent | |
Hedbys | The role of polysaccharides in corneal swelling | |
Schurer et al. | The use of polyethyleneimine for demonstration of anionic sites in basement membranes and collagen fibrils. | |
Lillie | Histochemical comparison of the Casella, Bauer, and periodic acid oxidation-Schiff leucofuchsin technics | |
CN112354013B (en) | Bionic collagen aqueous solution and preparation method and use method thereof | |
JPS6237020B2 (en) | ||
CN106267309B (en) | alginate composite antibacterial dressing and preparation method thereof | |
WO2022089287A1 (en) | Preparation method and use method for biomimetic collagen solution for skin surface | |
CN110339398A (en) | One kind Amvisc containing amino acid and preparation method thereof | |
CN102492158A (en) | Injectable in situ immobilization gel and its preparation method | |
CN100512889C (en) | Process of making cornea histoengineering support in bionic structure | |
GB1052589A (en) | ||
Duke-Elder | The physico-chemical properties of the vitreous body | |
US3553299A (en) | Process of producing shaped optical bodies useful as aids to vision | |
CN115233246A (en) | Tough collagen bandage material, and preparation method and application thereof | |
CN110845640B (en) | Heparinoid sulfonated citric acid modified chitosan and preparation method thereof | |
CN109337383B (en) | Collagen-based self-repairing hydrogel and preparation method thereof | |
CN114773629B (en) | Preparation method of injectable photo-curing hemostatic hydrogel for traumatic brain injury | |
US2831851A (en) | Polysulfuric acid esters of n-formyl chitosan | |
CN114805633A (en) | Gradient cross-linked sodium hyaluronate gel and preparation process thereof | |
CN113384749A (en) | Multifunctional hydrogel for promoting long-acting opening of blood circulation and preparation method thereof | |
CN112390900A (en) | Method for extracting chitosan from snow crab shells | |
JPH0122248B2 (en) | ||
DE102016011057B4 (en) | Lectin for the reversible immobilization of cells |